SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

426 hedge funds and large institutions have $5.49B invested in Sarepta Therapeutics in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 143 increasing their positions, 149 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
426
Holders Change
-33
Holders Change %
-7.19%
% of All Funds
5.79%
Holding in Top 10
5
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-54.55%
% of All Funds
0.07%
New
72
Increased
143
Reduced
149
Closed
101
Calls
$102M
Puts
$81.3M
Net Calls
+$21.1M
Net Calls Change
-$6.2M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62.6M
2
DTC
Deep Track Capital
Connecticut
+$57.4M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$37M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.9M
5
EC
EcoR1 Capital
California
+$33.3M

Top Sellers

1
O
OrbiMed
New York
-$117M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$86.4M
3
BlackRock
BlackRock
New York
-$82M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$67.8M
5
SPPAM
Summit Partners Public Asset Management
Massachusetts
-$46.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
TFM
526
TFC Financial Management
Massachusetts
– -$122 -1 Closed
18 19 20 21
22